CLINICAL OUTCOMES OF INTRA-ARTICULAR HIGH MOLECULAR WEIGHT HYALURONIC ACID INJECTION FOR HIP OSTEOARTHRITIS- A SYSTEMATIC REVIEW AND META-ANALYSIS

Authors

  • Sheikh Muhammad Ebad Ali Dr. Ruth K.M. Pfau Civil Hospital Karachi
  • Sofia Fatima Farooqui Dr Ruth KM Pfau Civil Hospital Karachi
  • Badaruddin Sahito Dow University of Health Sciences / Dr Ruth KM Pfau Civil Hospital Karachi
  • Maratib Ali Dow University of Health Sciences / Dr Ruth KM Pfau Civil Hospital Karachi
  • Ameer Ahmed Khan Dr Ruth KM Pfau Civil Hospital Karachi
  • Osama Naeem Dr Ruth KM Pfau Civil Hospital Karachi

Abstract

Osteoarthritis is the most common degenerative disease of the synovial joints in the elderly population with hip osteoarthritis as the second most commonly affected joint. A multitude of conservative treatments is used for pain relief and functional improvement including acetaminophen, NSAID, intra-articular corticosteroid, and viscosupplementation (VS). Different preparations of VS based on different molecular weights are commercially available. No systematic review or meta-analysis regarding the use of intra-articular high molecular weight hyaluronic acid (HMWHA) injection for the hip joint was published before. This review analyzes the efficacy of intra-articular HMWHA for hip osteoarthritis. Methods: PubMed, Google Scholar, Cochrane Library for randomized trials describing the efficacy of HMWHA for hip osteoarthritis was searched. The search terms were osteoarthritis, hip joint, outcomes, viscosupplementation, and high molecular weight hyaluronic acid in different combinations. Standardized mean difference (SMD) in VAS for pain relief and Lequesne index for functional outcomes while risk ratio (RR) for complications was used for data pooling. Result: Four studies comprising 185 and 189 patients in HMWHA and control groups were included, respectively. SMD for VAS and Lequesne index was -0.056 and -0.114, respectively while RR for complication was 0.879. Conclusion: Intra-articular HMWHA injection provided pain relief, functional improvement, and no severe complications on immediate short term basis. However, the results do not favor treatment with HMWHA over other treatment methods. Randomized trials are further necessary to provide data regarding comparisons between HMWHA for hip osteoarthritis concerning clinicians’ convenience, compliance, duration of relief, and cost-effectiveness.

References

Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage 2005;13(9):769–81.

Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58(1):26–35.

Murphy L, Helmick CG. The impact of osteoarthritis in the United States: a population-health perspective: A population-based review of the fourth most common cause of hospitalization in U.S. adults. Orthop Nurs 2012;31(2):85–91.

Robson EK, Hodder RK, Kamper SJ, O'Brien KM, Williams A, Lee H, et al. Effectiveness of Weight-Loss Interventions for Reducing Pain and Disability in People With Common Musculoskeletal Disorders: A Systematic Review With Meta-Analysis. J Orthop Sports Phys Ther 2020;50(6):319–33.

Teramoto Y, Fukushima K, Koyama T, Ohashi Y, Uchiyama K, Takahira N, et al. Impact of Jiggling Exercise as Conservative Treatment for Hip Osteoarthritis: A Report of Two Cases. Case Rep Orthop 2020;2020:2804193.

Wainwright TW, Immins T, Middleton RG. Hip osteoarthritis: patients with complex comorbidities can make exceptional improvements following intensive exercise and education. BMJ Case Rep 2015;2015:bcr2014208529.

Hawker GA, Croxford R, Bierman AS, Harvey P, Ravi B, Kendzerska T, et al. Osteoarthritis-related difficulty walking and risk for diabetes complications. Osteoarthritis Cartilage 2017;25(1):67–75.

Yamaguchi A, Goto K, Kawai T, Kuroda Y, Sano K, Matsuda S. Dose optimization of topical tranexamic acid for primary total hip arthroplasty: A prospective cohort study. J Orthop Sci 2019;24(2):275–9.

Vina ER, Hannon MJ, Masood HS, Hausmann LRM, Ibrahim SA, Dagnino J, et al. Nonsteroidal Anti-Inflammatory Drug Use in Chronic Arthritis Pain: Variations by Ethnicity. Am J Med 2020;133(6):733–40.

Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken) 2020;72(2):220–33.

Snijders GF, van den Ende CH, van den Bemt BJ, van Riel PL, van den Hoogen FH, den Broeder AA. Treatment outcomes of a Numeric Rating Scale (NRS)-guided pharmacological pain management strategy in symptomatic knee and hip osteoarthritis in daily clinical practice. Clin Exp Rheumatol 2012;30(2):164–70.

Flanagan J, Casale FF, Thomas TL, Desai KB. Intra-articular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl 1988;70(3):156–7.

Plant MJ, Borg AA, Dziedzic K, Saklatvala J, Dawes PT. Radiographic patterns and response to corticosteroid hip injection. Ann Rheumc Dis 1997;56(8):476–80.

Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2007;56(7):2278–87.

Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16(2):137–62.

Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 1967;10(4):357–76.

Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E. Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee. Am J Sports Med 2016;44(8):2158–65.

Ishikawa M, Yoshioka K, Urano K, Tanaka Y, Hatanaka T, Nii A. Biocompatibility of cross-linked hyaluronate (Gel-200) for the treatment of knee osteoarthritis. Osteoarthritis Cartilage 2014;22(11):1902–9.

Gigis I, Fotiadis E, Nenopoulos A, Tsitas K, Hatzokos I. Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis. Hippokratia 2016;20(1):26–31.

Migliore A, Giovannangeli F, Granata M, Laganà B. Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis. Clin Med Insights Arthritis Musculoskelet Disord 2010;3:55–68.

Elmorsy S, Funakoshi T, Sasazawa F, Todoh M, Tadano S, Iwasaki N. Chondroprotective effects of high-molecular-weight cross-linked hyaluronic acid in a rabbit knee osteoarthritis model. Osteoarthritis Cartilage 2014;22(1):121–7.

Tolba YM, Omar SS, Nagui DA, Nawwar MA. Effect of high molecular weight hyaluronic acid in treatment of osteoarthritic temporomandibular joints of rats. Arch Oral Biol 2020;110:104618.

Levillain A, Magoariec H, Boulocher C, Decambron A, Viateau V, Hoc T. Effects of a viscosupplementation therapy on rabbit menisci in an anterior cruciate ligament transection model of osteoarthritis. J Biomech 2017;58:147–54.

Liu Z, Lin W, Fan Y, Kampf N, Wang Y, Klein J. Effects of Hyaluronan Molecular Weight on the Lubrication of Cartilage-Emulating Boundary Layers. Biomacromolecules 2020;21(10):4345–54.

Pai SK, Allgar V, Giannoudis PV. Are intra-articular injections of Hylan G-F 20 efficacious in painful osteoarthritis of the knee? A systematic review & meta-analysis. Int J Clin Pract 2014;68(8):1041–7.

Colen S, Geervliet P, Haverkamp D, Van Den Bekerom MP. Intra-articular infiltration therapy for patients with glenohumeral osteoarthritis: A systematic review of the literature. Int J Shoulder Surg 2014;8(4):114–21.

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17(1):1–12.

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177–88.

Ellis PD. Effect size equations. 2009.

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557–60.

Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21(11):1559–73.

Spitzer AI, Bockow BI, Brander VA, Yates JW, MacCarter DK, Gudger GK, et al. Hylan G-F 20 improves hip osteoarthritis: a prospective, randomized study. Phys Sportsmed 2010;38(2):35–47.

Tikiz C, Unlü Z, Sener A, Efe M, Tüzün C. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 2005;24(3):244–50.

Clementi D, D'Ambrosi R, Bertocco P, Bucci MS, Cardile C, Ragni P, et al. Efficacy of a single intra-articular injection of ultra-high molecular weight hyaluronic acid for hip osteoarthritis: a randomized controlled study. Eur J Orthop Surg Traumatol 2018;28(5):915–22.

Richette P, Ravaud P, Conrozier T, Euller-Ziegler L, Mazières B, Maugars Y, et al. Effect of hyaluronic acid in symptomatic hip osteoarthritis: A multicenter, randomized, placebo-controlled trial. Arthritis Rheum 2009;60(3):824–30.

Thompson K, Kramarchuk M, Yagnatovsky M, Kunichoff D, Zacchilli M, Campbell KA, et al. Pain catastrophizing is associated with increased physical disability in patients with anterior knee pain. J Orthop 2020;21:283–6.

Zampogna B, Papalia R, Papalia GF, Campi S, Vasta S, Vorini F, et al. The Role of Physical Activity as Conservative Treatment for Hip and Knee Osteoarthritis in Older People: A Systematic Review and Meta-Analysis. J Clin Med 2020;9(4):1167.

Ceballos-Laita L, Jiménez-Del-Barrio S, Marín-Zurdo J, Moreno-Calvo A, Marín-Boné J, Albarova-Corral MI, et al. Effects of dry needling on pain, pressure pain threshold and psychological distress in patients with mild to moderate hip osteoarthritis: Secondary analysis of a randomized controlled trial. Complement Ther Med 2020;51:102443.

Walter SS, Wintermeyer E, Klinger C, Lorbeer R, Rathmann W, Peters A, et al. Association between metabolic syndrome and hip osteoarthritis in middle-aged men and women from the general population. PloS One 2020;15(3):e0230185.

Kendzerska T, King LK, Lipscombe L, Croxford R, Stanaitis I, Hawker GA. The impact of hip and knee osteoarthritis on the subsequent risk of incident diabetes: a population-based cohort study. Diabetologia 2018;61(11):2290–9.

Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests. Scand J Rheumatol Suppl 1987;65:85–9.

Lecorney J, Verhoeven F, Chouk M, Guillot X, Prati C, Wendling D. Correlation between catastrophizing and Lequesne index in case of osteoarthritis of the knee: A prospective study. Joint Bone Spine 2018;85(5):605–7.

Lahm A, Dabravolski D, Rödig J, Esser J, Erggelet C, Kasch R. Varying development of femoral and tibial subchondral bone tissue and their interaction with articular cartilage during progressing osteoarthritis. Arch Orthop Trauma Surg 2020;140(12):1919–30.

Driban JB, Harkey MS, Barbe MF, Ward RJ, MacKay JW, Davis JE, et al. Risk factors and the natural history of accelerated knee osteoarthritis: a narrative review. BMC Musculoskelet Disord 2020;21(1):332.

Wieczorek M, Rotonda C, Coste J, Pouchot J, Saraux A, Guillemin F, et al. Trajectory analysis combining pain and physical function in individuals with knee and hip osteoarthritis: results from the French KHOALA cohort. Rheumatology (Oxford) 2020;59(11):3488–98.

Ohtsuki T, Asano K, Inagaki J, Shinaoka A, Kumagishi-Shinaoka K, Cilek MZ, et al. High molecular weight hyaluronan protects cartilage from degradation by inhibiting aggrecanase expression. J Orthop Res 2018;36(12):3247–55.

Lengers I, Herrmann F, Le Borgne M, Jose J. Improved Surface Display of Human Hyal1 and Identification of Testosterone Propionate and Chicoric Acid as New Inhibitors. Pharmaceuticals (Basel 2020;13(4):54.

Pochon L, Peterson CK, Sutter R, Del Grande F, Ulbrich EJ, Pfirrmann CW. Hip MRI findings and outcomes following imaging-guided hip injections. Br J Radiol 2020;93(1108):20190817.

Zarringam D, Saris DBF, Bekkers JEJ. Identification of early prognostic factors for knee and hip arthroplasty; a long-term follow-up of the CHECK cohort. J Orthop 2020;19:41–5.

Cassuto D, Delledonne M, Zaccaria G, Illiano I, Giori AM, Bellia G. Safety Assessment of High- and Low-Molecular-Weight Hyaluronans (Profhilo®) as Derived from Worldwide Postmarketing Data. Biomed Res Int 2020;2020:8159047.

Rivera F. Single intra-articular injection of high molecular weight hyaluronic acid for hip osteoarthritis. J Orthop Traumatol 2016;17(1):21–6.

Downloads

Published

2021-04-29